{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T12:13:57Z","timestamp":1775477637624,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T00:00:00Z","timestamp":1739318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T00:00:00Z","timestamp":1739318400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"DOI":"10.1186\/s13104-024-07029-7","type":"journal-article","created":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T13:38:21Z","timestamp":1739367501000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Is ketamine efficacious for rapid treatment of acute suicidal ideation in an emergency setting? Lessons learned from a pilot randomized controlled trial"],"prefix":"10.1186","volume":"18","author":[{"given":"Maryam","family":"Barzkar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaveh","family":"Alavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazem","family":"Malakouti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamad-Amin","family":"Khajeh-Azad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farzaneh","family":"Barzkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir Hossein","family":"Jalali Nadoushan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Niakan","family":"Lahiji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,12]]},"reference":[{"issue":"3","key":"7029_CR1","doi-asserted-by":"publisher","first-page":"251","DOI":"10.4103\/0971-9962.193202","volume":"32","author":"MC Kastrup","year":"2016","unstructured":"Kastrup MC. Health Coverage and Mental Illness: the ongoing issue of Mental Health gap (mhGAP). Indian J Social Psychiatry. 2016;32(3):251\u20133.","journal-title":"Indian J Social Psychiatry"},{"key":"7029_CR2","unstructured":"World Health O. mhGAP intervention guide for mental, neurological and substance use disorders in non-specialized health settings: mental health Gap Action Programme (mhGAP). version 2.0 ed. Geneva: World Health Organization; 2016 2016."},{"issue":"3","key":"7029_CR3","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.mcna.2016.12.006","volume":"101","author":"AN Weber","year":"2017","unstructured":"Weber AN, Michail M, Thompson A, Fiedorowicz JG. Psychiatric emergencies: assessing and managing suicidal ideation. Med Clin North Am. 2017;101(3):553\u201371.","journal-title":"Med Clin North Am"},{"issue":"2","key":"7029_CR4","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1177\/2045125313507739","volume":"4","author":"C Caddy","year":"2014","unstructured":"Caddy C, Giaroli G, White TP, Shergill SS, Tracy DK. Ketamine as the prototype glutamatergic antidepressant: pharmacodynamic actions, and a systematic review and meta-analysis of efficacy. Therapeutic Adv Psychopharmacol. 2014;4(2):75\u201399.","journal-title":"Therapeutic Adv Psychopharmacol"},{"key":"7029_CR5","doi-asserted-by":"publisher","first-page":"204512532091665","DOI":"10.1177\/2045125320916657","volume":"10","author":"D Matveychuk","year":"2020","unstructured":"Matveychuk D, Thomas RK, Swainson J, Khullar A, MacKay MA, Baker GB, et al. Ketamine as an antidepressant: overview of its mechanisms of action and potential predictive biomarkers. Therapeutic Adv Psychopharmacol. 2020;10:2045125320916657.","journal-title":"Therapeutic Adv Psychopharmacol"},{"issue":"1","key":"7029_CR6","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/sltb.12663","volume":"51","author":"ED Ballard","year":"2021","unstructured":"Ballard ED, Fields J, Farmer CA, Zarate CA Jr. Clinical trials for rapid changes in suicidal ideation: lessons from ketamine. Suicide Life-Threatening Behav. 2021;51(1):27\u201335.","journal-title":"Suicide Life-Threatening Behav"},{"key":"7029_CR7","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.jpsychires.2021.03.009","volume":"137","author":"AN Siegel","year":"2021","unstructured":"Siegel AN, Di Vincenzo JD, Brietzke E, Gill H, Rodrigues NB, Lui LM, et al. Antisuicidal and antidepressant effects of ketamine and esketamine in patients with baseline suicidality: a systematic review. J Psychiatr Res. 2021;137:426\u201336.","journal-title":"J Psychiatr Res"},{"key":"7029_CR8","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.jpsychires.2021.03.009","volume":"137","author":"AN Siegel","year":"2021","unstructured":"Siegel AN, Di Vincenzo JD, Brietzke E, Gill H, Rodrigues NB, Lui LMW, et al. Antisuicidal and antidepressant effects of ketamine and esketamine in patients with baseline suicidality: a systematic review. J Psychiatr Res. 2021;137:426\u201336.","journal-title":"J Psychiatr Res"},{"issue":"2","key":"7029_CR9","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1176\/appi.ajp.2017.17040472","volume":"175","author":"ST Wilkinson","year":"2018","unstructured":"Wilkinson ST, Ballard ED, Bloch MH, Mathew SJ, Murrough JW, Feder A, et al. The Effect of a single dose of intravenous ketamine on suicidal ideation: a systematic review and individual Participant Data Meta-Analysis. Am J Psychiatry. 2018;175(2):150\u20138.","journal-title":"Am J Psychiatry"},{"issue":"1","key":"7029_CR10","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1177\/0004867419883341","volume":"54","author":"K Witt","year":"2019","unstructured":"Witt K, Potts J, Hubers A, Grunebaum MF, Murrough JW, Loo C, et al. Ketamine for suicidal ideation in adults with psychiatric disorders: a systematic review and meta-analysis of treatment trials. Australian New Z J Psychiatry. 2019;54(1):29\u201345.","journal-title":"Australian New Z J Psychiatry"},{"issue":"4","key":"7029_CR11","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1176\/appi.ajp.2017.17060647","volume":"175","author":"MF Grunebaum","year":"2018","unstructured":"Grunebaum MF, Galfalvy HC, Choo TH, Keilp JG, Moitra VK, Parris MS, et al. Ketamine for Rapid reduction of suicidal thoughts in Major Depression: a midazolam-controlled Randomized Clinical Trial. Am J Psychiatry. 2018;175(4):327\u201335.","journal-title":"Am J Psychiatry"},{"issue":"7","key":"7029_CR12","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1038\/s41386-019-0317-8","volume":"44","author":"ST Wilkinson","year":"2019","unstructured":"Wilkinson ST, Farmer C, Ballard ED, Mathew SJ, Grunebaum MF, Murrough JW, et al. Impact of midazolam vs. saline on effect size estimates in controlled trials of ketamine as a rapid-acting antidepressant. Neuropsychopharmacology. 2019;44(7):1233\u20138.","journal-title":"Neuropsychopharmacology"},{"key":"7029_CR13","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.jpsychires.2015.06.003","volume":"68","author":"ED Ballard","year":"2015","unstructured":"Ballard ED, Luckenbaugh DA, Richards EM, Walls TL, Brutsche NE, Ameli R, et al. Assessing measures of suicidal ideation in clinical trials with a rapid-acting antidepressant. J Psychiatr Res. 2015;68:68\u201373.","journal-title":"J Psychiatr Res"},{"issue":"1","key":"7029_CR14","first-page":"862","volume":"29","author":"M Esfahani","year":"2015","unstructured":"Esfahani M, Hashemi Y, Alavi K. Psychometric assessment of Beck scale for suicidal ideation (BSSI) in general population in Tehran. MJIRI. 2015;29(1):862\u201371.","journal-title":"MJIRI"},{"key":"7029_CR15","first-page":"603","volume":"12","author":"M Ahmadpanah","year":"2016","unstructured":"Ahmadpanah M, Sheikhbabaei M, Haghighi M, Roham F, Jahangard L, Akhondi A, et al. Validity and test-retest reliability of the Persian version of the Montgomery-Asberg Depression Rating Scale. Neuropsychiatr Dis Treat. 2016;12:603\u20137.","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"12","key":"7029_CR16","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1176\/appi.ajp.161.12.2163","volume":"161","author":"RM Bagby","year":"2004","unstructured":"Bagby RM, Ryder AG, Schuller DR, Marshall MB. The Hamilton Depression Rating Scale: has the gold standard become a lead weight? Am J Psychiatry. 2004;161(12):2163\u201377.","journal-title":"Am J Psychiatry"},{"issue":"1","key":"7029_CR17","first-page":"268","volume":"29","author":"M Esfahani","year":"2015","unstructured":"Esfahani M, Hashemi Y, Alavi K. Psychometric assessment of Beck scale for suicidal ideation (BSSI) in general population in Tehran. Med J Islam Repub Iran. 2015;29(1):268.","journal-title":"Med J Islam Repub Iran"},{"issue":"6","key":"7029_CR18","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1111\/cns.12099","volume":"19","author":"G Mion","year":"2013","unstructured":"Mion G, Villevieille T. Ketamine pharmacology: an update (pharmacodynamics and molecular aspects, recent findings). CNS Neurosci Ther. 2013;19(6):370\u201380.","journal-title":"CNS Neurosci Ther"},{"issue":"1","key":"7029_CR19","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1186\/s12903-023-03061-4","volume":"23","author":"MS Hauge","year":"2023","unstructured":"Hauge MS, Willumsen T, Stora B. Changes in symptoms of anxiety, depression, and PTSD in an RCT-study of dentist-administered treatment of dental anxiety. BMC Oral Health. 2023;23(1):415.","journal-title":"BMC Oral Health"},{"key":"7029_CR20","doi-asserted-by":"crossref","unstructured":"Abbar M, Demattei C, El-Hage W, Llorca P-M, Samalin L, Demaricourt P et al. Ketamine for the acute treatment of severe suicidal ideation: double blind, randomised placebo controlled trial. BMJ. 2022;376.","DOI":"10.1136\/bmj-2021-067194"},{"issue":"3","key":"7029_CR21","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/da.22975","volume":"37","author":"Y Domany","year":"2020","unstructured":"Domany Y, Shelton RC, McCullumsmith CB. Ketamine for acute suicidal ideation. An emergency department intervention: a randomized, double-blind, placebo\u2010controlled, proof\u2010of\u2010concept trial. Depress Anxiety. 2020;37(3):224\u201333.","journal-title":"Depress Anxiety"},{"issue":"3","key":"7029_CR22","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/da.22975","volume":"37","author":"Y Domany","year":"2020","unstructured":"Domany Y, Shelton RC, McCullumsmith CB. Ketamine for acute suicidal ideation. An emergency department intervention: a randomized, double-blind, placebo-controlled, proof-of-concept trial. Depress Anxiety. 2020;37(3):224\u201333.","journal-title":"Depress Anxiety"},{"key":"7029_CR23","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jad.2022.07.054","volume":"315","author":"KS Chen","year":"2022","unstructured":"Chen KS, Dwivedi Y, Shelton RC. The effect of IV ketamine in patients with major depressive disorder and elevated features of borderline personality disorder. J Affect Disord. 2022;315:13\u20136.","journal-title":"J Affect Disord"},{"issue":"5","key":"7029_CR24","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1097\/00131746-200009000-00005","volume":"6","author":"PS LINKS","year":"2000","unstructured":"LINKS PS, Boggild A, Sarin N. Modeling the relationship between affective lability, impulsivity, and suicidal behavior in patients with borderline personality disorder. J Psychiatric Practice\u00ae. 2000;6(5):247\u201355.","journal-title":"J Psychiatric Practice\u00ae"},{"issue":"2","key":"7029_CR25","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1080\/00332747.2019.1600219","volume":"82","author":"MM Rizk","year":"2019","unstructured":"Rizk MM, Choo T-H, Galfalvy H, Biggs E, Brodsky BS, Oquendo MA, et al. Variability in suicidal ideation is associated with affective instability in suicide attempters with borderline personality disorder. Psychiatry. 2019;82(2):173\u20138.","journal-title":"Psychiatry"},{"issue":"3","key":"7029_CR26","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/YCO.0000000000000925","volume":"37","author":"S Barlati","year":"2024","unstructured":"Barlati S, Nibbio G, Vita A. Evidence-based psychosocial interventions in schizophrenia: a critical review. Curr Opin Psychiatry. 2024;37(3):131\u20139.","journal-title":"Curr Opin Psychiatry"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-024-07029-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13104-024-07029-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-024-07029-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T10:53:24Z","timestamp":1739444004000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/s13104-024-07029-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,12]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7029"],"URL":"https:\/\/doi.org\/10.1186\/s13104-024-07029-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4718815\/v1","asserted-by":"object"}]},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,12]]},"assertion":[{"value":"10 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics committee at Iran University of Medical Sciences (Ethics reference: IR.IUMS.FMD.REC.1399.069). Written informed consent was obtained from patients and their legal guardians(as an additional ethical safeguard) prior to enrollment. This decision was made to ensure transparency and to inform guardians about their loved ones\u2019 involvement in the research, particularly given the sensitive nature of the study topic.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All participants provided written informed consent that their anonymous data be shared.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"65"}}